While some chronic conditions are influenced by the direct metabolic and hormonal effects of the medication, others improve due to the weight loss caused by the medication
What Science Currently Says So lets address the main question directly
Nat Struct Mol Biol
This study suggests a slightly increased risk of a rare but serious eye condition among people with type 2 diabetes starting GLP-1 receptor agonists compared with those starting SGLT-2 inhibitors or DPP-4 inhibitors
Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP: Carnitine replacement in end-stage renal disease and hemodialysis
At Bio-X Weight Loss Center in Round Rock and Austin, Texas, were passionate about helping our patients achieve their weight loss goals